4.5 Article

Sociodemographic and psychiatric determinants of attrition in the Netherlands Study of Depression and Anxiety (NESDA)

Journal

COMPREHENSIVE PSYCHIATRY
Volume 53, Issue 1, Pages 63-70

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.comppsych.2011.01.011

Keywords

-

Categories

Funding

  1. Netherlands Organisation for Health Research and Development
  2. European Union
  3. Stanley Medical Research Institute
  4. Astra Zeneca
  5. Eli Lilly
  6. GlaxoSmithKline
  7. Wyeth
  8. Pfizer
  9. Servier
  10. Netherlands Organisation for Health Research and Development (ZonMw) [10-000-1002]
  11. VU University Medical Center
  12. GGZ inGeest
  13. Arkin
  14. Leiden University Medical Center
  15. GGZ Rivierduinen
  16. University Medical Center Groningen
  17. Lentis
  18. GGZ Friesland
  19. GGZ Drenthe
  20. IQ Healthcare
  21. Netherlands Institute for Health Services Research [NIVEL]
  22. Netherlands Institute of Mental Health and Addiction [Trimbos]

Ask authors/readers for more resources

Background: Although attrition is inevitable in longitudinal epidemiological studies, psychiatric studies are thought to be especially sensitive to attrition. This study aimed to evaluate the sociodemographic and psychiatric determinants of attrition at 2-year follow-up in the Netherlands Study of Depression and Anxiety. Methods: Logistic regression was used to examine sociodemographic and psychiatric determinants of attrition and the influence of clinical psychiatric characteristics on attrition. In addition, differences in determinants between 3 types of attrition (refusal, noncontact, and not able to participate) were evaluated. Results: The attrition rate at the 2-year follow-up assessment was 12.9% (385/2981), representing 6 deceased persons, 250 refusers, 51 noncontacts, and 78 persons unable to participate because of health reasons. Determinants of attrition were younger age, less years of education, not being of North European descent, being recruited in Amsterdam, no previous participation in research, and having major depressive disorder. Only the effects of age, sampling site, and previous participation in research differed between types of attrition. Furthermore, comorbid depressive and anxiety disorders and higher symptom severity were associated with attrition. Conclusions: In contrast to the view that psychiatric epidemiological research is more prone to high attrition rates, this study revealed a relatively low attrition rate. Furthermore, both sociodemographic and psychiatric variables were independent determinants of attrition. Oversampling of subgroups that are at higher risk of dropout may be advisable for future psychiatric cohort studies. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available